Simply Wall St.
Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings
➖
AI Sentiment
Neutral
4/10
Nuvation Bio Inc. News
Latest updates and market news for NUVB
3 news
Mar 17 - Mar 23, 2026
Page 1
Insider Monkey
Bullish Analyst Sentiment on Nuvation Bio (NUVB) Amid Early Commercialization Progress
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
📈
AI Sentiment
Highly Positive
9/10
Share this news page